Gait apraxia

Summary

Gait apraxia (MONDO:0006766) is a disease and 5 clinical trials. A subtype of apraxia — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Clinical trials: 5

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	gait apraxia
Mondo ID	MONDO:0006766
MeSH	D020235
DOID	DOID:4260
UMLS	C1510417
MedGen	266930
MedDRA	10070635
Is cancer (heuristic)	no

Also known as: Gait apraxia (finding)

Disease family

This is a subtype of apraxia. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › nervous system disorder › perceptual disorders › apraxia › gait apraxia

Related subtypes (1): ideomotor apraxia

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 5.

Phase distribution (across all retrieved trials)

Phase	Trials
Not specified	5

Top trials by phase / activity

NCT	Phase	Status	Title
NCT03020381	Not specified	RECRUITING	Gait as Predictor of Dementia and Falls. The Gait and Brain Cohort Study
NCT01314638	Not specified	UNKNOWN	Study of Adherence and Effects of Balance Exercices (SIEL BLEU Associatio)
NCT01315704	Not specified	UNKNOWN	Alzheimer’s Disease and Related Disorders
NCT01315717	Not specified	COMPLETED	Gait and Alzheimer Interaction Tracking (GAIT) Study
NCT04557592	Not specified	COMPLETED	Comparisons of gaIt aNalyses pERformance Between the Gaitrite walkwaYs